 | • レポートコード：QYR9N7734 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗吸収薬、同化薬）、用途別（男性、女性）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・骨粗鬆症治療薬の世界市場規模 ・主要企業別市場シェア ・骨粗鬆症治療薬の世界市場規模：種類別（抗吸収薬、同化薬） ・骨粗鬆症治療薬の世界市場規模：用途別（男性、女性） ・骨粗鬆症治療薬のアメリカ市場規模（種類別、用途別） ・骨粗鬆症治療薬のヨーロッパ市場規模（種類別、用途別） ・骨粗鬆症治療薬の中国市場規模（種類別、用途別） ・骨粗鬆症治療薬の日本市場規模（種類別、用途別） ・骨粗鬆症治療薬の東南アジア市場規模（種類別、用途別） ・骨粗鬆症治療薬のインド市場規模（種類別、用途別） ・骨粗鬆症治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・骨粗鬆症治療薬の世界市場予測（2019年-2025年） ・骨粗鬆症治療薬の地域別市場予測（2019年-2025年） ... |
Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.Osteoporosis Drugs is a kind of medicine for Osteoporosis, such as Fosamax, Actonel, Boniva, Zoledronic Acid (Reclast or Zometa) and others.
Osteoporosis, which literally means porous bone, is a disease in which the density and quality of bone are reduced. As bones become more porous and fragile, the risk of fracture is greatly increased. The loss of bone occurs silently and progressively. Often there are no symptoms until the first fracture occurs. Osteoporosis drugs are a kind of medicine for Osteoporosis. The types of osteoporosis drugs mainly include antiresorptive drugs and anabolic drugs.
The Brazil osteoporosis drugs is Very concentrated, the sales of top eight manufacturers account exceeds 70% of Brazil sales.
In 2018, the global Osteoporosis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Osteoporosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteoporosis Therapeutics development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Novartis
Pfizer
Amgen
Merck
Novo nordisk
Actavis
Roche
Market segment by Type, the product can be split into
Antiresorptive Drugs
Anabolic Drugs
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Osteoporosis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Osteoporosis Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Osteoporosis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Osteoporosis Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antiresorptive Drugs
1.4.3 Anabolic Drugs
1.5 Market by Application
1.5.1 Global Osteoporosis Therapeutics Market Share by Application (2014-2025)
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Osteoporosis Therapeutics Market Size
2.2 Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Osteoporosis Therapeutics Market Size by Regions (2014-2025)
2.2.2 Osteoporosis Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Osteoporosis Therapeutics Market Size by Manufacturers
3.1.1 Global Osteoporosis Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Osteoporosis Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Osteoporosis Therapeutics Key Players Head office and Area Served
3.3 Key Players Osteoporosis Therapeutics Product/Solution/Service
3.4 Date of Enter into Osteoporosis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Osteoporosis Therapeutics Market Size by Type (2014-2019)
4.2 Global Osteoporosis Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Osteoporosis Therapeutics Market Size (2014-2019)
5.2 Osteoporosis Therapeutics Key Players in United States
5.3 United States Osteoporosis Therapeutics Market Size by Type
5.4 United States Osteoporosis Therapeutics Market Size by Application
6 Europe
6.1 Europe Osteoporosis Therapeutics Market Size (2014-2019)
6.2 Osteoporosis Therapeutics Key Players in Europe
6.3 Europe Osteoporosis Therapeutics Market Size by Type
6.4 Europe Osteoporosis Therapeutics Market Size by Application
7 China
7.1 China Osteoporosis Therapeutics Market Size (2014-2019)
7.2 Osteoporosis Therapeutics Key Players in China
7.3 China Osteoporosis Therapeutics Market Size by Type
7.4 China Osteoporosis Therapeutics Market Size by Application
8 Japan
8.1 Japan Osteoporosis Therapeutics Market Size (2014-2019)
8.2 Osteoporosis Therapeutics Key Players in Japan
8.3 Japan Osteoporosis Therapeutics Market Size by Type
8.4 Japan Osteoporosis Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Osteoporosis Therapeutics Market Size (2014-2019)
9.2 Osteoporosis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Osteoporosis Therapeutics Market Size by Type
9.4 Southeast Asia Osteoporosis Therapeutics Market Size by Application
10 India
10.1 India Osteoporosis Therapeutics Market Size (2014-2019)
10.2 Osteoporosis Therapeutics Key Players in India
10.3 India Osteoporosis Therapeutics Market Size by Type
10.4 India Osteoporosis Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Osteoporosis Therapeutics Market Size (2014-2019)
11.2 Osteoporosis Therapeutics Key Players in Central & South America
11.3 Central & South America Osteoporosis Therapeutics Market Size by Type
11.4 Central & South America Osteoporosis Therapeutics Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Osteoporosis Therapeutics Introduction
12.1.4 Eli Lilly Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Osteoporosis Therapeutics Introduction
12.2.4 Novartis Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Osteoporosis Therapeutics Introduction
12.3.4 Pfizer Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Osteoporosis Therapeutics Introduction
12.4.4 Amgen Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Osteoporosis Therapeutics Introduction
12.5.4 Merck Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Novo nordisk
12.6.1 Novo nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Osteoporosis Therapeutics Introduction
12.6.4 Novo nordisk Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.6.5 Novo nordisk Recent Development
12.7 Actavis
12.7.1 Actavis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Osteoporosis Therapeutics Introduction
12.7.4 Actavis Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.7.5 Actavis Recent Development
12.8 Roche
12.8.1 Roche Company Details
12.8.2 Company Description and Business Overview
12.8.3 Osteoporosis Therapeutics Introduction
12.8.4 Roche Revenue in Osteoporosis Therapeutics Business (2014-2019)
12.8.5 Roche Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Osteoporosis Therapeutics Key Market Segments
Table Key Players Osteoporosis Therapeutics Covered
Table Global Osteoporosis Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Osteoporosis Therapeutics Market Size Market Share by Type 2014-2025
Figure Antiresorptive Drugs Figures
Table Key Players of Antiresorptive Drugs
Figure Anabolic Drugs Figures
Table Key Players of Anabolic Drugs
Table Global Osteoporosis Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Male Case Studies
Figure Female Case Studies
Figure Osteoporosis Therapeutics Report Years Considered
Table Global Osteoporosis Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Osteoporosis Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Osteoporosis Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Osteoporosis Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Osteoporosis Therapeutics Market Share by Regions 2014-2019
Figure Global Osteoporosis Therapeutics Market Share by Regions 2014-2019
Figure Global Osteoporosis Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Osteoporosis Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Osteoporosis Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Osteoporosis Therapeutics Market Share by Manufacturers in 2018
Table Global Osteoporosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Osteoporosis Therapeutics Product/Solution/Service
Table Date of Enter into Osteoporosis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Osteoporosis Therapeutics Market Size Share by Type (2014-2019)
Figure Global Osteoporosis Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Osteoporosis Therapeutics Market Size Share by Application (2014-2019)
Figure Global Osteoporosis Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Osteoporosis Therapeutics Revenue Market Share by Application in 2018
Figure United States Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table United States Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table United States Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Europe Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table Europe Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Europe Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure China Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table China Osteoporosis Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table China Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Japan Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table Japan Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Japan Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table Southeast Asia Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure India Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table India Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table India Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Osteoporosis Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Osteoporosis Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Osteoporosis Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Osteoporosis Therapeutics Market Share (2018-2019)
Table Central & South America Osteoporosis Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Osteoporosis Therapeutics Market Share by Type (2014-2019)
Table Central & South America Osteoporosis Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Osteoporosis Therapeutics Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Osteoporosis Therapeutics Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Merck Company Details
Table Merck Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novo nordisk Company Details
Table Novo nordisk Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Novo nordisk Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Novo nordisk Recent Development
Table Actavis Company Details
Table Actavis Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Actavis Recent Development
Table Roche Company Details
Table Roche Revenue in Osteoporosis Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Osteoporosis Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Global Osteoporosis Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Osteoporosis Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Osteoporosis Therapeutics Market Size Share by Regions in 2025
Figure United States Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Osteoporosis Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Osteoporosis Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Osteoporosis Therapeutics Market Size by Product (2019-2025)
Figure Global Osteoporosis Therapeutics Market Size by Product in 2025
Table Global Osteoporosis Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Osteoporosis Therapeutics Market Size by Application (2019-2025)
Figure Global Osteoporosis Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の閉経後骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. In 2018, the globa…- 世界の不眠症治療薬市場：市場規模・現状・予測 In 2018, the global Insomnia Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Insomnia Therapeutics Drugs status, future forecast, growth opportunity, key market and key playe…
- 世界の肝疾患治療薬市場：市場規模・現状・予測 In 2018, the global Liver Diseases Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market a…
- 世界の女性の健康治療市場：市場規模・現状・予測 Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.Rise in cases of infertility and increas…
- 世界のウィルソン病薬市場：市場規模・現状・予測 In 2018, the global Wilson's Disease Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Wilson's Disease Drugs status, future forecast, growth opportunity, key market and key playe…